Found 3 hits Enz. Inhib. hit(s) with Target = 'Glucagon receptor' and Ligand = 'BDBM50007225' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007225
(CHEMBL3238217)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(F)cc(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(30.08,-13.9,;30.07,-12.36,;28.72,-11.6,;28.73,-13.11,;31.39,-11.57,;31.37,-10.03,;32.7,-9.25,;32.64,-7.71,;33.85,-6.76,;35.33,-7.17,;33.32,-5.31,;31.78,-5.37,;31.36,-6.85,;30.18,-5.86,;28.73,-6.4,;28.47,-7.91,;29.65,-8.9,;31.1,-8.37,;27.03,-8.45,;25.84,-7.46,;25.58,-8.98,;26.77,-9.96,;34.1,-3.98,;33.34,-2.65,;34.11,-1.32,;33.35,.03,;35.65,-1.32,;36.41,-2.66,;37.95,-2.67,;35.64,-3.99,;34.02,-10.03,;34,-11.58,;35.32,-12.36,;36.67,-11.61,;36.69,-10.07,;35.37,-9.29,;37.99,-12.4,;37.97,-13.94,;39.33,-11.65,;40.66,-12.43,;42,-11.68,;43.4,-12.31,;44.44,-11.18,;43.68,-9.84,;42.18,-10.14,)| Show InChI InChI=1S/C34H43F2N7O2/c1-32(2,3)14-13-27(21-7-9-22(10-8-21)30(44)37-20-28-39-41-42-40-28)43-31(45)29(23-17-25(35)19-26(36)18-23)38-34(43)15-11-24(12-16-34)33(4,5)6/h7-10,17-19,24,27H,11-16,20H2,1-6H3,(H,37,44)(H,39,40,41,42)/t24-,27-,34-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from recombinant human GCGR expressed in CHO cells after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007225
(CHEMBL3238217)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(F)cc(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(30.08,-13.9,;30.07,-12.36,;28.72,-11.6,;28.73,-13.11,;31.39,-11.57,;31.37,-10.03,;32.7,-9.25,;32.64,-7.71,;33.85,-6.76,;35.33,-7.17,;33.32,-5.31,;31.78,-5.37,;31.36,-6.85,;30.18,-5.86,;28.73,-6.4,;28.47,-7.91,;29.65,-8.9,;31.1,-8.37,;27.03,-8.45,;25.84,-7.46,;25.58,-8.98,;26.77,-9.96,;34.1,-3.98,;33.34,-2.65,;34.11,-1.32,;33.35,.03,;35.65,-1.32,;36.41,-2.66,;37.95,-2.67,;35.64,-3.99,;34.02,-10.03,;34,-11.58,;35.32,-12.36,;36.67,-11.61,;36.69,-10.07,;35.37,-9.29,;37.99,-12.4,;37.97,-13.94,;39.33,-11.65,;40.66,-12.43,;42,-11.68,;43.4,-12.31,;44.44,-11.18,;43.68,-9.84,;42.18,-10.14,)| Show InChI InChI=1S/C34H43F2N7O2/c1-32(2,3)14-13-27(21-7-9-22(10-8-21)30(44)37-20-28-39-41-42-40-28)43-31(45)29(23-17-25(35)19-26(36)18-23)38-34(43)15-11-24(12-16-34)33(4,5)6/h7-10,17-19,24,27H,11-16,20H2,1-6H3,(H,37,44)(H,39,40,41,42)/t24-,27-,34-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-stimulated cAMP production preincubated for 30 mins follo... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Mus musculus) | BDBM50007225
(CHEMBL3238217)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(F)cc(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(30.08,-13.9,;30.07,-12.36,;28.72,-11.6,;28.73,-13.11,;31.39,-11.57,;31.37,-10.03,;32.7,-9.25,;32.64,-7.71,;33.85,-6.76,;35.33,-7.17,;33.32,-5.31,;31.78,-5.37,;31.36,-6.85,;30.18,-5.86,;28.73,-6.4,;28.47,-7.91,;29.65,-8.9,;31.1,-8.37,;27.03,-8.45,;25.84,-7.46,;25.58,-8.98,;26.77,-9.96,;34.1,-3.98,;33.34,-2.65,;34.11,-1.32,;33.35,.03,;35.65,-1.32,;36.41,-2.66,;37.95,-2.67,;35.64,-3.99,;34.02,-10.03,;34,-11.58,;35.32,-12.36,;36.67,-11.61,;36.69,-10.07,;35.37,-9.29,;37.99,-12.4,;37.97,-13.94,;39.33,-11.65,;40.66,-12.43,;42,-11.68,;43.4,-12.31,;44.44,-11.18,;43.68,-9.84,;42.18,-10.14,)| Show InChI InChI=1S/C34H43F2N7O2/c1-32(2,3)14-13-27(21-7-9-22(10-8-21)30(44)37-20-28-39-41-42-40-28)43-31(45)29(23-17-25(35)19-26(36)18-23)38-34(43)15-11-24(12-16-34)33(4,5)6/h7-10,17-19,24,27H,11-16,20H2,1-6H3,(H,37,44)(H,39,40,41,42)/t24-,27-,34-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from GCGR in mouse liver membranes after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Search and Browse
